Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemzar vs Doxil in Platinum-Resistant Ovarian Cancer
NCT00191607Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Eli Lilly and Company. Started Jul 2002; status: completed.
02
Drugs
gemcitabine
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00191607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00191607.